Discover investment opportunities in Therapeutics Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Therapeutics Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Therapeutics Stocks using our Smart AI Filter.
8 stocks found for "Therapeutics Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
0.60 | ±39.2% | 20.8 | 0.00% | |||
0.30 | ±26.0% | 12.1 | 0.66% | |||
2.32 | ±96.8% | -0.7 | 0.00% | |||
0.63 | ±47.5% | -28.2 | 0.00% | |||
0.61 | ±31.4% | 19.2 | 0.00% | |||
0.70 | ±46.8% | 1.5 | 0.00% | |||
0.62 | ±41.3% | -11.5 | 0.00% | |||
0.36 | ±26.9% | 24.5 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Q: How has Vertex Pharmaceuticals (VRTX) historically performed in economic downturns?
A: Vertex Pharmaceuticals, primarily focused on cystic fibrosis treatments, has shown resilience during economic downturns due to the critical nature of its therapies. Their robust pipeline and consistent revenue from established treatments may offer stability compared to other sectors.
Q: What are the key investment appeals of Amgen (AMGN) for growth-focused investors?
A: Amgen appeals to growth-focused investors due to its strong R&D pipeline, expansion into biosimilars, and significant revenue from blockbuster drugs. Their strategic acquisitions also aim to sustain long-term growth.
Q: Does Regeneron Pharmaceuticals (REGN) offer opportunities for dividend-oriented investors?
A: Regeneron Pharmaceuticals does not currently offer dividends, focusing instead on reinvestment in R&D to drive future growth. Dividend-seeking investors may need to consider other biotech firms with established payout histories.
Q: What geographic markets does Biogen (BIIB) primarily target, and why is this significant for investors?
A: Biogen primarily targets North America and Europe, markets crucial for its neurology-focused treatments. These regions provide robust healthcare infrastructure and regulatory environments that support innovative therapies.
Q: How do economic conditions affect Gilead Sciences (GILD)?
A: Economic conditions generally have a limited impact on Gilead Sciences due to its focus on essential antiviral therapies. However, shifts in healthcare policy or pricing may affect revenue.
Q: What potential risks might investors face with Moderna (MRNA) focused solely on mRNA technology?
A: Investors face risks with Moderna's focus on mRNA technology if competitive pressures or scientific advancements in this area render current treatments obsolete. Market acceptance and regulatory hurdles also pose significant factors.
Investors with an interest in Medical - Drugs stocks have likely encountered both Grifols (GRFS) and Neurocrine Biosciences (NBIX). But which of these two stocks offers value investors a better bang for their buck right now?
Read more